I found this story a bit confusing: http://www.meassociation.org.uk/201...-latest-nhs-drugs-the-times-21-november-2014/ but it looks interesting. I'm wondering if it could help us get Rituximab faster, if the Norwegian and UK trial evidence is good. What do you think, @Jonathan Edwards? I couldn't quite make sense of how they would do the new assessments and how they would personalise the treatments. It doesn't seem to be RCT-based. I'm having trouble reading long screeds of text at the moment, though, and it's maybe clearer than I'm finding it.